ARWR

Arrowhead Pharmaceuticals (ARWR)

About Arrowhead Pharmaceuticals (ARWR)

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Details

Daily high

$82.53

Daily low

$79.68

Price at open

$80.00

52 Week High

$84.55

52 Week Low

$14.30

Market cap

11.6B

Dividend yield

0.00%

Volume

600,703

Avg. volume

1.6M

P/E ratio

-38.17

Arrowhead Pharmaceuticals News